BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31601997)

  • 21. Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma.
    Gauglhofer C; Paur J; Schrottmaier WC; Wingelhofer B; Huber D; Naegelen I; Pirker C; Mohr T; Heinzle C; Holzmann K; Marian B; Schulte-Hermann R; Berger W; Krupitza G; Grusch M; Grasl-Kraupp B
    Carcinogenesis; 2014 Oct; 35(10):2331-8. PubMed ID: 25031272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
    Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
    Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Established gastric cancer cell lines transplantable into C57BL/6 mice show fibroblast growth factor receptor 4 promotion of tumor growth.
    Yamamoto M; Nomura S; Hosoi A; Nagaoka K; Iino T; Yasuda T; Saito T; Matsushita H; Uchida E; Seto Y; Goldenring JR; Kakimi K; Tatematsu M; Tsukamoto T
    Cancer Sci; 2018 May; 109(5):1480-1492. PubMed ID: 29532565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer.
    Turkington RC; Longley DB; Allen WL; Stevenson L; McLaughlin K; Dunne PD; Blayney JK; Salto-Tellez M; Van Schaeybroeck S; Johnston PG
    Cell Death Dis; 2014 Feb; 5(2):e1046. PubMed ID: 24503538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FGFR4 signaling couples to Bim and not Bmf to discriminate subsets of alveolar rhabdomyosarcoma cells.
    Wachtel M; Rakic J; Okoniewski M; Bode P; Niggli F; Schäfer BW
    Int J Cancer; 2014 Oct; 135(7):1543-52. PubMed ID: 24550147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of fibroblast growth factor receptor 4 in cancer.
    Tang S; Hao Y; Yuan Y; Liu R; Chen Q
    Cancer Sci; 2018 Oct; 109(10):3024-3031. PubMed ID: 30070748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FGFR2 gene amplification in gastric cancer predicts sensitivity to the selective FGFR inhibitor AZD4547.
    Xie L; Su X; Zhang L; Yin X; Tang L; Zhang X; Xu Y; Gao Z; Liu K; Zhou M; Gao B; Shen D; Zhang L; Ji J; Gavine PR; Zhang J; Kilgour E; Zhang X; Ji Q
    Clin Cancer Res; 2013 May; 19(9):2572-83. PubMed ID: 23493349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGFR4 and its novel splice form in myogenic cells: Interplay of glycosylation and tyrosine phosphorylation.
    Kwiatkowski BA; Kirillova I; Richard RE; Israeli D; Yablonka-Reuveni Z
    J Cell Physiol; 2008 Jun; 215(3):803-17. PubMed ID: 18186042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGFR4: A promising therapeutic target for breast cancer and other solid tumors.
    Levine KM; Ding K; Chen L; Oesterreich S
    Pharmacol Ther; 2020 Oct; 214():107590. PubMed ID: 32492514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?
    Heinzle C; Erdem Z; Paur J; Grasl-Kraupp B; Holzmann K; Grusch M; Berger W; Marian B
    Curr Pharm Des; 2014; 20(17):2881-98. PubMed ID: 23944363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression.
    Lang L; Shull AY; Teng Y
    Curr Cancer Drug Targets; 2019; 19(1):17-25. PubMed ID: 29557750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural insights into FGFR kinase isoform selectivity: diverse binding modes of AZD4547 and ponatinib in complex with FGFR1 and FGFR4.
    Tucker JA; Klein T; Breed J; Breeze AL; Overman R; Phillips C; Norman RA
    Structure; 2014 Dec; 22(12):1764-1774. PubMed ID: 25465127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGFR4 polymorphic alleles modulate mitochondrial respiration: A novel target for somatostatin analog action in pituitary tumors.
    Ezzat S; Wang R; Pintilie M; Asa SL
    Oncotarget; 2017 Jan; 8(2):3481-3494. PubMed ID: 27966451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer.
    Xu M; Chen S; Yang W; Cheng X; Ye Y; Mao J; Wu X; Huang L; Ji J
    Cell Physiol Biochem; 2018; 47(1):151-160. PubMed ID: 29763898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
    Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer.
    Hong CS; Sun EG; Choi JN; Kim DH; Kim JH; Ryu KH; Shim HJ; Hwang JE; Bae WK; Kim HR; Kim KK; Jung C; Chung IJ; Cho SH
    Cancer Sci; 2020 Sep; 111(9):3268-3278. PubMed ID: 32533590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma.
    Futami T; Okada H; Kihara R; Kawase T; Nakayama A; Suzuki T; Kameda M; Shindoh N; Terasaka T; Hirano M; Kuromitsu S
    Mol Cancer Ther; 2017 Jan; 16(1):68-75. PubMed ID: 27837028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression.
    Ye YW; Zhou Y; Yuan L; Wang CM; Du CY; Zhou XY; Zheng BQ; Cao X; Sun MH; Fu H; Shi YQ
    Cancer; 2011 Dec; 117(23):5304-13. PubMed ID: 21567388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer.
    Hu L; Cong L
    Oncol Rep; 2015 Nov; 34(5):2683-91. PubMed ID: 26323668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGFR4 promotes nuclear localization of GABP to inhibit cell apoptosis in uterine leiomyosarcoma.
    Zhang P; Zhang H; Wang Y
    Cell Tissue Res; 2021 Feb; 383(2):865-879. PubMed ID: 33151453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.